Aldeyra Therapeutics, Inc. - Common Stock (ALDX)
CUSIP: 01438T106
Q3 2016 13F Holders as of 30 Sep 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,794,743
- Total 13F shares
- 6,112,780
- Share change
- -245,663
- Total reported value
- $47,882,100
- Price per share
- $7.82
- Number of holders
- 22
- Value change
- -$1,304,703
- Number of buys
- 8
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01438T106:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.2%
|
1,940,458
|
$11,041,000 | — | 30 Jun 2016 | |
| FMR LLC |
13F
|
Company |
3%
|
1,797,811
|
$10,230,000 | — | 30 Jun 2016 | |
| AWM Investment Company, Inc. |
13F
|
Company |
1.5%
|
917,810
|
$5,222,000 | — | 30 Jun 2016 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.62%
|
368,500
|
$2,097,000 | — | 30 Jun 2016 | |
| Boxer Capital, LLC |
13F
|
Company |
0.49%
|
291,230
|
$1,657,000 | — | 30 Jun 2016 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.45%
|
267,764
|
$1,524,000 | — | 30 Jun 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.24%
|
142,000
|
$808,000 | — | 30 Jun 2016 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.23%
|
135,800
|
$773,000 | — | 30 Jun 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.22%
|
130,500
|
$743,000 | — | 30 Jun 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.21%
|
125,125
|
$712,000 | — | 30 Jun 2016 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.13%
|
77,500
|
$441,000 | — | 30 Jun 2016 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.11%
|
65,610
|
$373,000 | — | 30 Jun 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
26,977
|
$153,000 | — | 30 Jun 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.03%
|
20,630
|
$117,000 | — | 30 Jun 2016 | |
| CROFT-LEOMINSTER INC |
13F
|
Company |
0.03%
|
17,000
|
$96,000 | — | 30 Jun 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
12,366
|
$70,000 | — | 30 Jun 2016 | |
| FNY Managed Accounts LLC |
13F
|
Company |
0.01%
|
5,000
|
$28,450 | — | 30 Jun 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,887
|
$22,000 | — | 30 Jun 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
3,254
|
$18,000 | — | 30 Jun 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
2,978
|
$17,000 | — | 30 Jun 2016 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0%
|
2,499
|
$14,000 | — | 30 Jun 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
1,457
|
$8,000 | — | 30 Jun 2016 | |
| Walleye Trading LLC |
13F
|
Company |
0%
|
1,400
|
$8,000 | — | 30 Jun 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
941
|
$5,000 | — | 30 Jun 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Jun 2016 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock (ALDX) as of Q3 2016
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2016 vs Q2 2016 Across Filers
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 Value $ | Q3 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.